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etronidazole from the new PEG/NaY and
PEG/MCM-41 nanocomposites
Mojgan Zendehdel1*, Giuseppe Cruciani2, Forozan Sahra Kar1 and Abolfazl Barati3Abstract
Recently, hybrid materials using poly ethylene glycol and porous nanocrystals have been developed for drug
release. In this study, a series of poly ethylene glycol (PEG)/NaY zeolite and PEG/MCM-41 nanocomposites get
synthesized. These materials are characterized using FT-IR spectroscopy, XRD, TGA and SEM. After loading the
metronidazole onto these nanocomposites, the release of Metronidazole was studied in two kinds of release fluids
simulating body fluid KH2PO4-Na2HPO4 buffer (pH = 7.4) and gastric fluid (HCl aqueous solution, pH = 1.5) while
controlling the time, pH values, and temperature using UV–vis. Results showed that these nanocomposites have
further release related to NaY, MCM-41 and the order of release in two pH solutions was PEG/NaY > PEG/MCM-41 >
NaY > MCM-41. The behavior of drug release in these nanocomposites is probably due to hydrogen bonding
interactions between drug and the hydroxyl group on the composite framework.
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Controlled and sustained release of drugs is important for
patients requiring medicinal treatment around the clock.
Controlled release has been used extensively in food, agri-
culture and pharmaceutical industries to deliver active
substances such as drugs, pesticides, herbicides and fer-
tilizers [1]. There are many groups of materials that take
advantage of a controlled release system such as den-
drimers [2], zeolites [3,4], polymers [5], MCM-41 [6], and
organic–inorganic composite materials [7].
Although, controlled drug delivery technologies using
polymers as carriers including natural or synthetic poly-
mers represent one of the most rapidly advancing areas of
science [8]. But, in recent years, there has been a con-
stantly increasing interest in the application of porous
silica or aluminosilcate materials as drug carriers for con-
trolled drug release in order to meet the requirements for
prolonged and better control of drug administration. Also,
porous materials fulfill the requirements for homogenous
distribution of drugs through the matrix in contrast to the* Correspondence: m-zendehdel@araku.ac.ir
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distribution, and reproduction in any mediumconventionally used polymeric materials. Nano-sized par-
ticles with a well-defined morphology are receiving wide
spread interest as advanced materials on the basis of a
large surface area and unique physical and chemical pro-
perties which are different from bulk solids.
However inorganic materials (clay, zeolite and MCM-41)
have important advantages such as high chemical and
mechanical stability and low toxicity and porous structure
that can be tailored to control the diffusion rate of an
adsorbed or encapsulated drug; but these materials have
some problems when using them in aqueous solutions
and are less studied as carriers of drugs compared to
organic materials such as polymers [9]. When these mate-
rials are used in aqueous solutions in all of the appli-
cations, an accumulation of them have been observed.
Under physiological conditions, porous material disper-
sion is unstable due to high concentrations of salt. In re-
cent years, some polymers such as poly ethylene glycol
(PEG), showed steric effects which would help to stabilize
the nanoparticles preventing them from agglomeration or
dispersion in solutions [7]. PEG has been bound to silica
through direct esterification of hydroxyl groups of its sur-
face and the silica's surface silanols or through a urethane
linkage in order to stabilize colloidal silica in water [10].tral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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face of the silica particles by means of hydrogen bonding;
in other cases the synthesis of the silica particles takes
place directly in the presence of PEG rendering ester link-
ages (Si-O-C) [11].
In this research, as a model drug, metronidazole (MTZ)
was used. MTZ is a nitroimidazole derivative, particularly
used in treatment of anaerobic bacteria and Protozoa
infections. MTZ is the drug of choice for treatment of
amoebiasis, an infection concerning the large intestine
caused by Entamoeba histolytica [12]. Metronidazole
(MTZ) is frequently used in treatment of periodontal
diseases since it can be used against several Gram-
negative anaerobic rods, the pathogenesis of periodontitis,
via inhibiting bacterial nucleic acid to synthesis [13].
In this contribution we tried to improve the controlled
release of metronidazole. In the first section we reported
the preparation and characterization of PEG/NaY zeolite
and PEG/MCM-41 and at the second section we used
them for releasing the metronidazole to achieve the best
condition possible for drug release.
Experimental
Poly (ethylene glycol) (PEG) M = 600), Cetyltrimethy-
lammonium bromide(C19TMABr), potassium hydroxide
(KOH), tetraethylorthosilicate(TEOS), N,N’ -methylen bis
acrylamide (MBA), hydrogen chloride, N, N, N′, N′-tetra
methyl ethylene diamine TMED), ammonium persulfate
(APS), aluminum hydroxide, silica gel, sodium hydroxide,
Metronidazole supplied by Merck. All of the mentioned
substances were used without further purification. The
Final product was characterized by X-ray Diffraction
(XRD) patterns for all samples were acquired by a Bruker
D8 Advance diffractometer equipped with a solid-state
detector (Sol-X) set to discriminate CuKa radiation
(15-130-2 h,0.02- step-scan, 10 s per step)., FT-IR (Galaxy
series FT-IR 5000 spectrometer) TGA (Diamond TG/DTA
Perkin Elmer). SEM (Philips, XL30).
Synthesis of NaY and MCM-41
2.1. MCM-41 was prepared in our laboratory as follow by
the previously mentioned method as follows: A gel com-
posite with molar composition: 1TEOS: 0.13 C19TMABr:
5.4 HCl: 150 H2O was prepared and stirred at room
temperature for 7 days. After filtering and washing with
water, the catalyst was characterized using the XRD. The
NaY zeolite was prepared and activated according to the
procedure described before [14,15].
Preparation of PEG/NaY zeolite and PEG/MCM-41
The best ratio for PEG/porous material achieved through
testing that which ratio has the first hour ; hence, the solu-
tion of 0.25 g PEG and 0.025 g N, N- methylene Bis acryl
amide was prepared. Then, 0.35 g porous material (NaYzeolite or MCM-41) after getting dispersed by sonication
was added to this solution and stirred for 30 min at room
temperature. We used Ammonium per sulfate (APS) to
beginnthe polymerization and N, N, N′, N′-tetra methyl
ethylene diamine (TMED) as initiator was used.
Preparation 0f PEG/porous material/metronidazole
0.35 g of porous material (NaY zeolite or MCM-41) was
added to a solution containing 0.30 g of metronidazole drug
and acetone; then the mixture was stirred for 2 hrs and it
got completely vaporized. After that, porous material/
Metronidazole was added to 0.25 g PEG and 0.025 g N,N’-
methylen bis acrylamide (MBA). The polymerization
process carried out using ammonium persulfate (APS) as
accelerator and N, N, N′, N′-tetra methyl ethylene dia-
mine (TMED) as initiator.
Metronidazole release from PEG/porous material
PEG/porous nanocomposite were suspended in 4 ml of
phosphate buffer for pH = 7.4 and pH = 1.5. we drew off
the buffer solution completely at preset sampling times,
and replaced it with a fresh buffer solution; Then the
Metronidazole solution was filtered and testing the drug
concentrations in the solution was performed by an
UV–VIS spectrophotometer at (landa = 274 nm for
pH = 1.5 and 317 nm for pH = 7.4).
Swelling studies
Water diffuses into the hydrogel network when it is
immersed into water. This diffusion into the network is
due to the osmotic pressure difference and water pene-
trates into the empty space between the chains. In order
to study the hydrogel swelling, the dried sample is
weighted, then immersed into 100 ml of distilled water
that is poured into a 250 ml beaker; After a while, the
sample is brought out, the excess water on its surface is
dried with a tissue, and the sample is weighted again in
particular time intervals. The final amount of swelling is
obtained by weighing the sample after 36 hours for the
last time, when no significant weight difference was ob-
served in two successive weightings. Results of the swell-
ing study is shown in Figure 1. Water absorption kinetics
is determined by weighing different amounts of absorbed
water by the gel in several time sequences. Eq. (1) is used
to calculate the swelling kinetics.
Mt=M∞ ¼ ktn ð1Þ
Where k is the hydrogel swelling constant, n is the
swelling ability, Mt is the amount of absorbed water at
time t, and M∞ is the amount of absorbed water by the
network at equilibrium time. The slope of the line ob-
tained by plotting ln(Mt/M∞) versus ln(t) shows the
values of n and k [16].
Figure 1 Swelling behaviour diagram of for PEG/NaY, PEG/MCM-41.
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XRD patterns of PEG/NaY nanocomposite before and
after the drug-loading process are shown in Figure 2a and
b. In Figure 2a the NaY zeolite peaks are observable. As
we can see, the structure of the zeolite does not collapse
and six characteristic peaks appear at 2 of 30.1°, 35.5°,
43.1°, 53.4°, 57.0° and62.6°, which are marked by their in-
dices ((2 2 0), (3 1 1), (4 00), (4 2 2), (5 1 1), and (4 4 0))
[17]. Figure 2b shows that the intensity of peaks decreased
after Metronidazole was loaded. Powder X-ray patterns of
PEG/MCM-41 nanocomposite before and after loading
the drug are shown in Figure 2c and d. In Figure 2c some
diffraction peaks at 2θ: 1–5 are clearly seen and can be
indexed as the MCM-41 that these peak decreased after
loading the mesoporous material (Figure 2d). Decrease of
intensity corresponds with covering the particles with the
composite [18].
Figure 3a-d show TGA/DTA curves for PEG/NaY and
PEG/MCM-41 nanocomposites before and after absorptionof Metronidazole. Figure 3a shows three peaks regarding
PEG/NaY, and the mass losses that took place at 0–110°C
are related to desorbtion of water. The PEG decompos-
ition can occur at 360°C that is about 14.03%. The last
step can be related to decomposition of structure of the
composite. Figure 3b shows three steps for PEG/NaY/
Metronidazole. The second step at 390°C can be assigned
to the decomposition and oxidation process of the Metro-
nidazole, which proves its presence in the composite
(18.31%). The PEG/MCM-41 at Figure 3c shows four
peaks that the first and second (280°C) steps are related to
desorbtion of water and surfactant (8.49 and 17.54%). The
PEG decomposition can occur at 370°C that is about
14.25%. The last step can be related to decomposition of
structure of the composite. Figure 3d shows four steps for
PEG/MCM-41/drug; the step at 310°C can be assigned to
decomposition and oxidation process of Metronidazole,
which proves its presence in the composite; hence, de-
composition of surfactant occurs in this temperature. We
Figure 2 XRD pattern for PEG/NaY before (a) after (b) drug loading, PEG/MCM-41 before (c) and after (d) drug loading.
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after adding the Metronidazole. Thus, thermal stability of
the composite increases when the ad micelles hosts the
Metronidazole [19,20]. Figure 4a-d show FT-IR spectra in
the range of 2000 to 4000 1/cm for PEG/NaY and PEG/
MCM-41 nanocomposites before and after of absorption
of Metronidazole. Figure 4a shows three peaks regarding
hydroxyl groups of Al-OH and Si-OH in pore materials.
In addition, we can see two bands at about 1070,743 cm-1
due to Si-O and 438 1/cm related to Al-OH in the com-
posites. The peaks of PEG around 1352 1/cm and 3416
1/cm correspond to O-H bond and two peaks about 2876
and 1456 1/cm related to C-H bonding are shown.
Figure 4c shows three peaks in regard to MCM-41 about
462,554 and 1103 1/cm. Also, the peaks related to PEG
are presented around 1352 1/cm , 3416 1/cm ( O-H bond)
along with two peaks about 2876 and 1456 1/cm (C-H
bond). We can see a sharp peak related to NO group
about 1531 1/cm and some chemical shift to lower ener-
gy for hydroxyl bond after loading the Metronidazole
(Figure 4b and d).
SEM images of the NaY zeolite, MCM-41, PEG/NaY
and nanocomposite are shown in Figure 5a-d, respec-
tively. There is a considerable change between two sam-
ples. From the micrographs, it was found that the NaY
and MCM-41 were dispersed in the polymer network.
Several areas show fine network structure. It means that
NaY and MCM-41 have good collaboration with PEG
and improve its network which may be promising for
drug adsorption [21].Swelling behavior
As it was mentioned before, the sample is synthesized by
changing one monomer composition when the others are
constant in each step. This changing in one monomer
composition leads to developing an optimized com-
position of synthesized gel. Thus, optimized gel has a
higher swelling rate in swelling experiments. The maxi-
mum amount of the swelling rate is 10 min for PEG/NaY
and 30 min for PEG/MCM-41 (Figure 1a,b). For the
higher time, the swelling rate decreases. The swelling ratio
of composite with hydrogel depends on the hydrophilicity
of the polymer chain, porous material and structure of
hydrogel network [22].
Drug release by PEG/porous materials
Release of metronidazole from NaY zeolite, MCM-41,
PEG/NaY and PEG/MCM- 41 was studied in phosphate
buffer solution pH = 7.4 and artificial gastric juice pH = 1.5.
Figure 6a and b show the degree of release of metro-
nidazole as a functional time under mild conditions in
HCl buffer (pH = 1.5) and KH2PO4-Na2HPO4 buffer
(pH = 7.4) at 37°C, respectively. The results show that
when we used the PEG alone, all of metronidazole was
released in the first minutes. The order of release of all
pH for hybrid materials were as follows: PEG/NaY >
PEG/MCM-41 > NaY >MCM-41. The results show that
Metronidazole release is about 70 percent in the first
hours which is very suitable for the fast release of drugs
in mouth and stomach [23]. The fast release of drugs in
mouth has attracted attention due to the advantages of
Figure 3 TGA/DTA for PEG/ NaY before (a) after (b) and, PEG/MCM-41 before (c) after (d) drug loading.
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Figure 4 FT-IR for PEG/NaY before (a) after (b) drug loading, PEG/MCM-41 before (c) after (d) drug loading.
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diatric and geriatric patients) find it difficult to swallow
tablets and hard gelatin capsules and tend not to take
their medication as prescribed. Also, there are some re-
searches that show local delivery of metronidazole has
been useful for periodontal treatment [13]. Nevertheless,
about 30% of the remaining metronidazole will not re-
lease until 8 hours after taking. The good stability ofFigure 5 SEM forNaY (a) MCM-41 (b) PEG/NaY (c), PEG/MCM-41 (d).these hybrids is suitable for releasing a drug within the
gastro intestinal tract (e.g. targeting the stomach).
The results show that the release rate for MCM-41
and PEG/MCM-41 is slower than NaY and NaY/PEG. It
has been widely demonstrated that the release of drug
from PEG/porous material depends on the strength and
nature of the drug and composite’s chemical bonds
(Figure 7). This can be explained by understanding the
Figure 6 Degree of release of the metrondazole as a functional time under mild conditions in HCl buffer (pH = 1.5) (a) and KH2PO4-Na2HPO4
buffer (pH =7.4) (b) at 37C.
Figure 7 Schematic representation of formation hydrogen bond interaction and ion exchange between drug and the polymer network
and the surface of zeolite, MCM-41.
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For the inclusion of metronidazole inside the channels, it
seems that it’s the hydrogen bond interaction between the
metronidazole molecule and the silanol groups which are
present in the pore wall that causes farther keeping of the
drug. It seems, NaY zeolite with Na56 (Al56 Si136 O384)
formula and by almost spherical cages (12A° of diameter)
tetrahedral interconnected through smaller windows (7.4A°
of diameter) defined by 12 oxygen rings is not a good ab-
sorbent for metronidazole related to MCM-41 because its
pore size is larger and hydrogen bond between zeolite and
metronidazole is weaker [24]. Also, literature review
shows that the drug release from NaY with Si/Al up to 60
is faster related to MCM-41 [4]. The results show that de-
livery rate of metronidazole increased when PEG was
added to MCM41 and NaY. The PEG is a hydrophilic
nonionic polymer that can be interacting from hydroxyl
group with surface of porous material and metronidazole
by hydrogen bonding. Different factors such as stability of
the composite and strength of bond between the drug and
the composite can affect on the rate of release. The hydro-
philic groups such as hydroxyl on the PEG and porous
material got hydrolyzed on the buffer solutions and it
seems like the hydrogen bond between metronidazole and
the composite is weaker than the porous material alone
and the rate of hydrolyzed increased [7,25,26].Figure 8 The effect of temperature on the release of metronidazole f
pH 1.5. and pH = 7.4.Also, Figures 8a-d show the effect of temperature on the
release of metronidazole for PEG/NaY and PEG/MCM-41
in pH = 7.4 and pH = 1.5. Results show that in pH = 1.5
with increasing the temperature, release of the drug
got increased and in pH = 7.4 with increasing the
temperature, release of the drug was decreased. It seems
when the temperature of the gel increases in acidic media,
the hydrated polymer begins to lose water, leading to in-
teractions between the side chains of the polymer and
proton, especially between the hydrophobic ones, which
to a large extent increases the viscosity of the gel and
metronidazole bond with composite will cleavage and de-
livery will be done. But, in pH = 7.4 with increasing the
temperature some of metronidazole that was hydrated be-
gins to lose water and interact with the composite, hence
the delivery rate decreases [27].
Conclusion
In this work poly ethylene glycol (PEG)/NaY zeolite and
PEG/MCM-41 nanocomposites were synthesized and
characterized using FT-IR spectroscopy, XRD, TGA and
SEM that results show good interactions between PEG
and porous material. In the second step metronidazole
loaded onto these nanocomposites .The release of metro-
nidazole was studied in pH = 7.4 and HCl aqueous solu-
tion and pH = 1.5 with controlled time and temperatureor PEG/NaY (a,b) in pH = 1.5. and pH 7.4 = PEG/MCM-41 (c,d) in
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have further release related to NaY and MCM-41 and order
of release in those two pH solutions were PEG/NaY >
PEG/MCM-41 >NaY >MCM-41 and about 70 percent of
the realease occurred in the first hours which is very suit-
able for the fast release of drugs in mouth and stomach. It
seems like this behavior of drug release for these nanocom-
posites is probably due to hydrogen bonding interactions
between drug and the hydroxyl group on the composite
framework.
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